ABBEYLINC 300 INJECTION

Nazione: Australia

Lingua: inglese

Fonte: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Principio attivo:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE

Commercializzato da:

ABBEY LABORATORIES PTY LTD

Forma farmaceutica:

PARENTERAL LIQUID/SOLUTION/SUSPENSION

Composizione:

LINCOMYCIN AS LINCOMYCIN HYDROCHLORIDE ANTIBIOTIC Active 300.0 mg/ml

Confezione:

100 mL

Classe:

VM - Veterinary Medicine

Area terapeutica:

ANTIBIOTIC & RELATED

Dettagli prodotto:

Poison schedule: 4; Withholding period: MEAT: DO NOT USE less than 2 days before slaughter for human consumption. Any v ariation by the prescribing veterinarian to the approved dose, frequency, durati on, route, disease or host animal may r esult in the need to extend the register ed withholding period. An ESI has not been established for this product. Note —observing the meat withholding period m ay not be sufficient to mitigate potenti al risks to export trade.. For advice o n the ESI, contact Abbey Animal Health P ty Ltd on 02 8088 0720 or the APVMA web site www.apvma.gov.au/residues.; Host/pest details: PIGS: [ARTHRITIS - INFECTIOUS, ERYSIPELOTHRIX SPP., MYCOPLASMA SPP., MYCOPLASMAL PNEUMONIA, STAPHYLOCOCCI, STREPTOCOCCI]

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2023-07-01

Foglio illustrativo

ABBEYLINC 300 INJECTION
86298/115363
Product Name:
APVMA Approval No:
Label Name:
ABBEYLINC 300 INJECTION
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
Constituent
Statements:
300 mg/mL LINCOMYCIN (as LINCOMYCIN HYDROCHLORIDE )
Claims:
For use by or under direction of a registered veterinarian
FOR INTRAMUSCULAR USE IN SWINE.
INDICATIONS
For the treatment of infections caused by micro-organisms sensitive to
lincomycin in swine.
Lincomycin is indicated for the treatment of infectious forms of
arthritis caused by
organisms sensitive to its activity. This includes most of the
organisms responsible
for the various infectious arthritides in swine such as the
Staphylococci, Streptococci,
Erysipelothrix and Mycoplasma spp.
Lincomycin is also indicated for the treatment of Mycoplasma
pneumonia.
Success in the treatment of viral diseases must be attributed to the
control of susceptible
secondary bacterial invaders rather than to any effect of Lincomycin
on the virus.
Resistance may develop to any chemical.
Net Contents:
100mL
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated in animals previously found to be
hypersensitive to
Lincomycin.
This product is contraindicated for use in animals with known
pre-existing monilial
infections. RLP APPROVED
This product is contraindicated for use in rabbits, hamsters, guinea
pigs and horses as
these species are sensitive to the gastrointestinal effects. The
administration of this product
should be avoided in these species.
Precautions:
The use of antibiotics occasionally results in overgrowth of
non-susceptible organisms
particularly yeasts. Should super infections occur, appropriate
measures should be taken.
Side Effects:
Intramuscularly and Intravenously, Lincomycin has demonstrated
excellent local tolerance
with no reports of pain or inflammation following injection.
The intramuscular administration to swine may cause a transient
diarrhea or loose stools.
Although this effect has rarely been repor

Scheda tecnica

_First Effective Date: 10_
_th_
_ of August 2018 _
_Page 1 of 6_
_ _
_ _
ABBEY ANIMAL HEALTH PTY LTD
_SAFETY DATA SHEET _
SUPPLIER COMPANY DETAILS: Abbey Animal Health Pty Ltd
ADDRESS: 39 Buckenderra Road, Middlingbank NSW 2630
TELEPHONE NUMBER: 02 8088 0720
FACSIMILE NUMBER: 02 8088 0721
EMERGENCY NUMBER: Australian Poisons Information Centre: 13 11 26 (24
Hour Service).
PRODUCT NAME
_ABBEYLINC 300 INJECTION _
_ _
PRODUCT USE
For the treatment of infections caused by micro-organisms sensitive to
Lincomycin in swine.
STATEMENT OF HAZARDOUS NATURE
This product is classified as: Not classified as hazardous according
to the criteria of SWA.
Not a Dangerous Good according to Australian Dangerous Goods (ADG)
Code, IATA or
IMDG/IMSBC criteria.
SUSMP CLASSIFICATION: S4
ADG CLASSIFICATION: None allocated. Not a Dangerous Good according to
Australian Dangerous
Goods (ADG) Code, IATA or IMDG/IMSBC criteria.
UN NUMBER: None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P262: Do not get in eyes, on skin, or on clothing.
P281: Use personal protective equipment as required.
RESPONSE
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
SECTION 1- IDENTIFICATION OF PRODUCT AND SUPPLIER
SECTION 2- HAZARDS IDENTIFICATION
_ABBEYLINC 300 INJECTION _
_First Effective Date: 10_
_th_
_ of August 2018 _
_Page 2 of 6_
_ _
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P410: Protect from sunlight.
P411: Store at temperatures not exceeding 25°C (Air Conditioning).
P402+P404: Store in a dry place. Store in a closed container.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping
with paper and putting
in garbage. For larger quantities, if recycling or reclaiming is not
possible, use a commercial
waste disposal service.
INGREDIENTS:
CHEMICAL NAME
CAS NUMBER
CONC, %
Lincomycin Hydrochloride
859-18-7
30
Non-hazardous ingredients
secret
to 100
_ _
_ _
_CALL POISONS INFORMATION CE